Literature DB >> 28228602

A divergent population of autoantigen-responsive CD4+ T cells in infants prior to β cell autoimmunity.

Anne-Kristin Heninger1, Anne Eugster1, Denise Kuehn1, Florian Buettner2, Matthias Kuhn3, Annett Lindner1, Sevina Dietz1, Sibille Jergens4, Carmen Wilhelm1, Andreas Beyerlein4,5, Anette-G Ziegler4,5,6, Ezio Bonifacio7,6,8,9.   

Abstract

Autoimmune diabetes is marked by sensitization to β cell self-antigens in childhood. We longitudinally followed at-risk children from infancy and performed single-cell gene expression in β cell antigen-responsive CD4+ T cells through pre- and established autoimmune phases. A striking divergence in the gene signature of β cell antigen-responsive naïve CD4+ T cells from children who developed β cell autoimmunity was found in infancy, well before the appearance of β cell antigen-specific memory T cells or autoantibodies. The signature resembled a pre-T helper 1 (TH1)/TH17/T follicular helper cell response with expression of CCR6, IL21, TBX21, TNF, RORC, EGR2, TGFB1, and ICOS, in the absence of FOXP3, IL17, and other cytokines. The cells transitioned to an IFNG-TH1 memory phenotype with the emergence of autoantibodies. We suggest that the divergent naïve T cell response is a consequence of genetic or environmental priming during unfavorable perinatal exposures and that the signature will guide future efforts to detect and prevent β cell autoimmunity.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28228602     DOI: 10.1126/scitranslmed.aaf8848

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  31 in total

1.  Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances.

Authors:  Simi Ahmed; Karen Cerosaletti; Eddie James; S Alice Long; Stuart Mannering; Cate Speake; Maki Nakayama; Timothy Tree; Bart O Roep; Kevan C Herold; Todd M Brusko
Journal:  Diabetes       Date:  2019-07       Impact factor: 9.461

2.  Anti-Insulin B Cells Are Poised for Antigen Presentation in Type 1 Diabetes.

Authors:  Jamie L Felton; Damian Maseda; Rachel H Bonami; Chrys Hulbert; James W Thomas
Journal:  J Immunol       Date:  2018-06-27       Impact factor: 5.422

Review 3.  Neoepitopes: a new take on beta cell autoimmunity in type 1 diabetes.

Authors:  Stuart I Mannering; Anthony R Di Carluccio; Colleen M Elso
Journal:  Diabetologia       Date:  2018-11-06       Impact factor: 10.122

Review 4.  Shared and unique immune alterations in pre-clinical autoimmunity.

Authors:  Samantha Slight-Webb; Rebecka L Bourn; V Michael Holers; Judith A James
Journal:  Curr Opin Immunol       Date:  2019-09-23       Impact factor: 7.486

5.  A peripheral blood transcriptomic signature predicts autoantibody development in infants at risk of type 1 diabetes.

Authors:  Ahmed M Mehdi; Emma E Hamilton-Williams; Alexandre Cristino; Anette Ziegler; Ezio Bonifacio; Kim-Anh Le Cao; Mark Harris; Ranjeny Thomas
Journal:  JCI Insight       Date:  2018-03-08

6.  New insight into type 1 diabetes development: resolving early diabetogenic CD4+ T cell responses that precede seroconversion.

Authors:  Sonja Schallenberg; Karsten Kretschmer
Journal:  Ann Transl Med       Date:  2018-02

7.  A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes.

Authors:  Isabelle Serr; Martin G Scherm; Adam M Zahm; Jonathan Schug; Victoria K Flynn; Markus Hippich; Stefanie Kälin; Maike Becker; Peter Achenbach; Alexei Nikolaev; Katharina Gerlach; Nicole Liebsch; Brigitta Loretz; Claus-Michael Lehr; Benedikt Kirchner; Melanie Spornraft; Bettina Haase; James Segars; Christoph Küper; Ralf Palmisano; Ari Waisman; Richard A Willis; Wan-Uk Kim; Benno Weigmann; Klaus H Kaestner; Anette-Gabriele Ziegler; Carolin Daniel
Journal:  Sci Transl Med       Date:  2018-01-03       Impact factor: 17.956

8.  T-Cell Epitopes and Neo-epitopes in Type 1 Diabetes: A Comprehensive Update and Reappraisal.

Authors:  Eddie A James; Roberto Mallone; Sally C Kent; Teresa P DiLorenzo
Journal:  Diabetes       Date:  2020-07       Impact factor: 9.461

9.  Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes.

Authors:  Alexander J Lakhter; Rachel E Pratt; Rachel E Moore; Kaitlin K Doucette; Bernhard F Maier; Linda A DiMeglio; Emily K Sims
Journal:  Diabetologia       Date:  2018-02-14       Impact factor: 10.122

10.  Single-Cell Analysis of CD4 T Cells in Type 1 Diabetes: From Mouse to Man, How to Perform Mechanistic Studies.

Authors:  Siddhartha Sharma; Jeremy Pettus; Michael Gottschalk; Brian Abe; Peter Gottlieb; Luc Teyton
Journal:  Diabetes       Date:  2019-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.